Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Lejla Hadzikadic‐Gusic"'
Autor:
Luis Costa, Rakesh Kumar, Cynthia Villarreal-Garza, Saket Sinha, Sunil Saini, Jayanti Semwal, Vartika Saxsena, Vaishali Zamre, Chintamani Chintamani, Mukurdipi Ray, Chikako Shimizu, Lejla Hadzikadic Gusic, Masakazu Toi, Allan Lipton
Publikováno v:
Breast, Vol 73, Iss , Pp 103623- (2024)
Despite advances in breast cancer care, breast cancer in young women (BCYW) faces unique challenges, diagnostic delays, and limited awareness in many countries. Here, we discuss the challenges and consequences associated with the delayed diagnosis of
Externí odkaz:
https://doaj.org/article/fbe7ddde39ee443ea4883eaf74001fb2
Autor:
Christine V. Pestana, Chad A. Livasy, Erin E. Donahue, Brittany Neelands, Antoinette R. Tan, Terry Sarantou, Lejla Hadzikadic-Gusic, Richard L. White
Publikováno v:
Annals of Surgical Oncology. 29:7716-7724
Autor:
Laura Hudson, Emily Reese, Anna Hecksher, Courtney Schepel, Sally J. Trufan, Adilen Cruz, Allison Verbyla, Richard L. White, Lejla Hadzikadic‐Gusic
Publikováno v:
Journal of Surgical Oncology. 126:239-246
Co-surgeon approach for bilateral mastectomy may lead to shorter operative times and improved outcomes compared with single-surgeon approach, but cost differences remain unclear. Economic models were applied to determine whether either approach offer
Autor:
Yancey, Warren, Anna, Hecksher, Courtney, Schepel, Sally, Trufan, Rebecca, Greiner, Susan, Yaguda, Chasse, Bailey-Dorton, Julie, Fisher, Richard, White, Lejla, Hadzikadic-Gusic
Publikováno v:
Oncology (Williston Park, N.Y.). 36(11)
Small studies have demonstrated the benefit of integrative oncology (IO) therapies in patients with breast cancer; however, referral patterns and timing of therapies are unknown. This study describes the referral pattern and utilization of IO service
Autor:
Christine V. Pestana, Chad A Livasy, Erin E Donahue, Brittany Neelands, Antoinette R. Tan, Terry Sarantou, Lejla Hadzikadic-Gusic, Richard L. White
Publikováno v:
Annals of surgical oncology. 29(12)
Autor:
Laura Hudson, Emily Reese, Anna Hecksher, Courtney Schepel, Sally J. Trufan, Adilen Cruz, Allison Verbyla, Richard L. White, Lejla Hadzikadic‐Gusic
Publikováno v:
Journal of Surgical Oncology. 126
Autor:
Erin A, Elder, Chad A, Livasy, Erin E, Donahue, Brittany, Neelands, Alicia, Patrick, Mckenzie, Needham, Terry, Sarantou, Lejla, Hadzikadic-Gusic, Arielle L, Heeke, Richard L, White
Publikováno v:
Annals of surgical oncology. 29(13)
The residual cancer burden class informs survival outcomes after neoadjuvant chemotherapy. We evaluated the prognostic ability of the RCB for survival outcomes in women with different phenotypic subtypes of breast cancer treated with neoadjuvant chem
Autor:
Erin A, Elder, Chad A, Livasy, Erin E, Donahue, Brittany, Neelands, Alicia, Patrick, Mckenzie, Needham, Terry, Sarantou, Lejla, Hadzikadic-Gusic, Arielle L, Heeke, Richard L, White
Publikováno v:
Annals of Surgical Oncology. 29:8071-8071
Autor:
Jacquelyn A.V. Palmer, Richard L. White, Myra M. Robinson, Kendall Walsh, Teresa S. Flippo-Morton, Terry Sarantou, Lejla Hadzikadic Gusic
Publikováno v:
Clinical Breast Cancer. 18:270-275
Background The ACOSOG (American College of Surgeons Oncology Group) Z1071 assessed the feasibility of performing sentinel lymph node biopsy (SLNB) in node-positive patients who completed neoadjuvant chemotherapy (NACT). Historically, adoption of clin
Autor:
Richard L. White, Meghan R. Forster, Lejla Hadzikadic-Gusic, Myra M. Robinson, Terry Sarantou, Kendall Walsh, Caitlin R. Patten
Publikováno v:
Journal of Surgical Oncology. 116:1040-1045
INTRODUCTION Prior to the "no ink on tumor" SSO/ASTRO consensus guideline, approximately 20% of women with stage I/II breast cancers undergoing breast conservation surgery at our institution underwent margin re-excision. On May 20, 2013, our institut